Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]-Reference-Cited by-同舟云学术

Eribulin as first-line treatment in older patients with advanced breast cancer: A multicenter phase II trial [SAKK 25/14]

Published:2023-01 Issue:1 Volume:14 Page:101372
ISSN:1879-4068
Container-title:Journal of Geriatric Oncology
language:en
Short-container-title:Journal of Geriatric Oncology

Author:

Hasler-Strub Ursula,Mueller Andreas,Li Qiyu,Thuerlimann Beat,Ribi Karin,Gerber Stefan,von Moos Roger,Fehr Mathias,Rochlitz Christoph,Zaman Khalil,Aebi Stefan,Hochstrasser Andreas,Gick Ute,Baertschi Daniela,Greuter Stefan,Schreiber Alexander,Caspar Clemens B.,Trojan Andreas,Condorelli Rosaria,Ruhstaller Thomas

Funder

Eisai Inc

Staatssekretariat für Bildung, Forschung und Innovation

Eisai

Krebsliga Schweiz

Swiss Cancer Research Foundation

Publisher

Elsevier BV

Subject

Geriatrics and Gerontology,Oncology

Reference18 articles.

1. Treatment of breast cancer in the elderly: a prospective, population-based Swiss study;Joerger;J Geriatr Oncol,2013

2. Outcomes of older women with hormone receptor-positive, human epidermal growth factor receptor-negative metastatic breast cancer treated with a CDK4/6 inhibitor and an aromatase inhibitor: an FDA pooled analysis;Howie;J Clin Oncol,2019

3. 5th ESO-ESMO international consensus guidelines for advanced breast cancer (ABC 5);Cardoso;Ann Oncol,2020

4. Management of elderly patients with breast cancer: updated recommendations of the International Society of Geriatric Oncology (SIOG) and European Society of Breast Cancer Specialists (EUSOMA);Biganzoli;Lancet Oncol,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The therapeutic potential and application of marine alkaloids in treating breast cancer;Frontiers in Marine Science;2024-07-15